European Society of Hypertension and Chinese Hypertension League Stroke in Hypertension Optimal Treatment Trial - ESH-CHL-SHOT

Istituto Auxologico Italiano0 sites7,500 target enrollmentJanuary 23, 2013

DrugsNA

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Patients with previous stroke (or transient ischaemic attack) and hypertension and hyperlipidaemia.
Sponsor: Istituto Auxologico Italiano
Enrollment: 7500
Status: Active, not recruiting
Last Updated: 5 years ago

No summary available.

Registry

who.int

Start Date

January 23, 2013

End Date

TBD

Last Updated

5 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

All

Sponsor

•Stroke or transient ischaemic attack during the previous 1 to 6 months; Age 65 years or older; Hypertension (\>140/90 mm Hg among untreated patients); Hyperlipidaemia (LDL\-cholesterol \>2\.8 mmol/L among untreated patients)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1\.2 Adults (18\-64 years) no
•F.1\.2\.1 Number of subjects for this age range
•F.1\.3 Elderly (\>\=65 years) yes
•F.1\.3\.1 Number of subjects for this age range 7500

•1\) Significant carotid artery stenosis; 2\) Secondary hypertension or treatment resistant hypertension; 3\) Treatment resistant hyperlipidaemia; 4\) Dementia; 5\) Functional disability (modified Rankin Scale score \>4\); 6\) Renal failure or liver disease; 7\) Reduced compliance.